Drug Profile
Avapritinib companion diagnostic - Blueprint Medicines/QIAGEN
Alternative Names: BLU-285 companion diagnostic - Blueprint Medicines/QIAGEN; Therascreen PDGFRA kit - Blueprint Medicines/QIAGEN; Therascreen PDGFRA RGQ PCR kit - Blueprint Medicines/QIAGENLatest Information Update: 09 Aug 2023
Price :
$50
*
At a glance
- Originator Blueprint Medicines; QIAGEN
- Class Diagnostic agents
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Registered Gastrointestinal stromal tumours
Most Recent Events
- 07 Aug 2023 Registered for Gastrointestinal stromal tumours (Diagnosis) in USA (unspecified route)
- 28 Sep 2020 No recent reports of development identified for research development in Gastrointestinal-stromal-tumours(Diagnosis) in Germany
- 28 Sep 2020 No recent reports of development identified for research development in Gastrointestinal-stromal-tumours(Diagnosis) in USA